Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

Matthew Zustiak from Thermo Fisher Scientific discusses the challenges of equipment choice for producing mAbs.

We dig into the story of Lonza in China, and its new HPAPI expansion in Guangzhou

Efficient, reliable scale up is a key component of mAb production. Thermo Fisher Scientific’s modularized system provides individual building blocks.

Efficient and reliable scale up is a key component of mAb production.

This Scottish company is developing a thin film that could improve medicine adherence in the elderly

Viral vectors can enable innovative medical treatments, but only with a comprehensive formulation development plan

Ukrainian drug discovery has been disrupted by war. We spoke to leaders of its largest player about the domestic industry’s past, present, and future.

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

From improving solubility and bioavailability to making formulations suitable for inhalation – micronization is a versatile technique.